Interpretation of clinical practice guide for postoperative lymphedema after breast cancer operation of Chinese Medical Association

doi:10.3877/cma.j.issn.1674-3946.2023.03.003

Abstract

Abstract:

The Chinese Medical Association's Clinical Practice Guide for Breast Surgery（2022）added a new chapter of clinical practice guideline about postoperative lymphedema of breast cancer. According to the Evidence-Based Medical evidences of diagnosis and treatment of postoperative lymphedema of breast cancer，referring to the GRADE standard and following the principle of clinical diagnosis and treatment accessibility，this guideline present recommendations on the high-risk population，diagnosis，staging，treatment and postoperative rehabilitation of postoperative lymphedema of breast cancer in grades. In this paper，combined with practical clinical experience，the key contents of the guideline are interpreted for the reference of relevant people.

Key words: Lymphedema, Clinical practice guideline, Interpretation

Xue Bai, Jun Li, Chan Xing, Jiyue Gao, Haidong Zhao. Interpretation of clinical practice guide for postoperative lymphedema after breast cancer operation of Chinese Medical Association[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 245-249.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2023.03.003

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2023/V17/I03/245

References 41

[1]	Sung H，Ferlay J，Siegel RL，et al. Global Cancer Statistics 2020：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries［J］. CA Cancer J Clin，2021，71（3）：209-249.
[2]	Bernas M，Thiadens SRJ，Stewart P，et al. Secondary lymphedema from cancer therapy［J］. Clin Exp Metastasis，2022，39（1）：239-247.
[3]	Salinas-Huertas S，Luzardo-González A，Vázquez-Gallego S，et al. Risk factors for lymphedema after breast surgery：A prospective cohort study in the era of sentinel lymph node biopsy［J］. Breast Dis，2022，41（1）：97-108.
[4]	Akezaki Y，Tominaga R，Kikuuchi M. Risk Factors for Lymphedema in Breast Cancer Survivors Following Axillary Lymph Node Dissection［J］. Prog Rehabili Med，2019，4：20190021.
[5]	Brahma B，Yamamoto T. Breast cancer treatment-related lymphedema（BCRL）：An overview of the literature and updates in microsurgery reconstructions［J］. Eur J Surg Oncol，2019，45（7）：1138-1145.
[6]	He L，Qu H，Wu Q，et al. Lymphedema in survivors of breast cancer［J］. Oncol Lett，2020，19（3）：2085-2096.
[7]	Donker M，van Tienhoven G，Straver ME，et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer（EORTC 10981-22023 AMAROS）：a randomised，multicentre，open-label，phase 3 non-inferiority trial［J］. Lancet Oncol，2014，15（12）：1303-1310.
[8]	Gowda AU，Nie J，Mets E，et al. Risk Factors for Lymphedema After Breast Conservation Therapy and Oncoplastic Reduction［J］. Ann Plast Surg，2021，87（3）：248-252.
[9]	Rockson SG. The Role of Body Mass Index in Breast Cancer-Associated Lymphedema［J］. Lymphat Res Biol，2020，18（6）：501.
[10]	Ana Carolina Padula Ribeiro Pereira，Koifman RJ，Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment：10 years of follow-up［J］. Breast，2017，36：67-73.
[11]	Gillespie TC，Sayegh HE，Brunelle CL，et al. Breast cancer-related lymphedema：risk factors，precautionary measures，and treatments［J］. Gland Surg，2018，7（4）：379-403.
[12]	Zhu W，Li D，Li X，et al. Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema［J］. Anticancer Drugs，2017，28（3）：350-355.
[13]	Swaroop MN，Ferguson CM，Horick NK，et al. Impact of adjuvant taxane-based chemotherapy on development of breast cancer-related lymphedema：results from a large prospective cohort［J］. Breast Cancer Res Treat，2015，151（2）：393-403.
[14]	Kim M，Park IH，Lee KS，et al. Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy［J］. Cancer Res Ttreat，2015，47（3）：416-423.
[15]	Committee E. The Diagnosis and Treatment of Peripheral Lymphedema：2016 Consensus Document of the International Society of Lymphology［J］. Lymphology，2016，49（4）：170-184.
[16]	Brunelle CL，Taghian AG. ASO Author Reflections：Breast Cancer-Related Lymphedema—A Suggested Clinical Pathway for Diagnosis［J］. Ann Surg Oncol，2022，29（2）：1003-1004.
[17]	Byun HK，Chang JS，Im SH，et al. Risk of Lymphedema Following Contemporary Treatment for Breast Cancer：An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective［J］. Ann Surg，2021，274（1）：170-178.
[18]	Forte AJ，Huayllani MT，Boczar D，et al. Use of bioimpedance spectroscopy for prospective surveillance and early diagnosis of breast cancer-related lymphedema［J］. Breast Dis，2021，40（2）：85-93.
[19]	Erdinc Gunduz N，Dilek B，Sahin E，et al. Diagnostic Contribution of Ultrasonography in Breast Cancer-Related Lymphedema［J］. Lymphat Res Biol，2021，19（6）：517-523.
[20]	Kim G，Donohoe K，Smith MP，et al. Use of non-contrast MR in diagnosing secondary lymphedema of the upper extremities［J］. Clin Imaging，2021，80：400-405.
[21]	Yamamoto T，Yamamoto N，Ishiura R. Indocyanine Green Lymphography for Lymphedema Screening following Breast Cancer Treatment［J］. Plast Reconstr Surg，2017，139（6）：1365e-1366e.
[22]	Akita S，Unno N，Maegawa J，et al. A phase Ⅲ，multicenter，single-arm study to assess the utility of indocyanine green fluorescent lymphography in the treatment of secondary lymphedema［J］. J Vasc Surg Venous Lymphat Disord，2022，10（3）：728-737.e3.
[23]	Gentili F，Mazzei FG，Monteleone I，et al. Comparison of indocyanine green fluorescence lymphangiography and magnetic resonance lymphangiography to investigate lymphedema of the extremities［J］. Ann Ital Chir，2021，92：452-459.
[24]	Nelson NL. Breast Cancer-Related Lymphedema and Resistance Exercise：A Systematic Review［J］. J Strength Cond Res，2016，30（9）：2656-2665.
[25]	Chang DW，Dayan J，Greene AK，et al. Surgical Treatment of Lymphedema：A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference［J］. Plast Reconstr Surg，2021，147（4）：975-993.
[26]	Chen K，Sinelnikov MY，Shchedrina MA，et al. Surgical Management of Postmastectomy Lymphedema and Review of the Literature［J］. Ann Plast Surg，2021，86（3S Suppl 2）：S173-S176.
[27]	Chollet C，Malloizel-Delaunay J，Cabarrou B，et al. Liposuction-assisted brachioplasty in breast cancer-related lymphedema：Impact on volume reduction and quality of life［J］. J Plast Reonstr Aesthet Surg，2021，74（7）：1633-1701.
[28]	Karlsson T，Karlsson M，Ohlin K，et al. Liposuction of Breast Cancer-Related Arm Lymphedema Reduces Fat and Muscle Hypertrophy［J］. Lymphat Res Biol，2022，20（1）：53-63.
[29]	Campisi C，Bellini C，Campisi C，et al. Microsurgery for lymphedema：clinical research and long-term results［J］. Microsurgery，2010，30（4）：256-260.
[30]	Chang DW，Suami H，Skoracki R. Reply：a prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema［J］. Plast Reconstr Surg，2014，133（6）：888e-889e.
[31]	Chen WF，Yamamoto T，Fisher M，et al. The "Octopus" Lymphaticovenular Anastomosis：Evolving Beyond the Standard Supermicrosurgical Technique［J］. J Reconstr Microsurg，2015，31（6）：450-457.
[32]	Mihara M，Hara H，Furniss D，et al. Lymphaticovenular anastomosis to prevent cellulitis associated with lymphoedema［J］. Br J Surg，2014，101（11）：1391-1396.
[33]	Qiu SS，Pruimboom T，Cornelissen AJM，et al. Outcomes following lymphaticovenous anastomosis（LVA）for 100 cases of lymphedema：results over 24-months follow-up［J］. Breast Cancer Res Treat，2020，184（1）：173-183.
[34]	Wolfs JAGN，de Joode LGEH，van der Hulst RRWJ，et al. Correlation between patency and clinical improvement after lymphaticovenous anastomosis（LVA）in breast cancer-related lymphedema：12-month follow-up［J］. Breast Cancer Res Treat，2020，179（1）：131-138.
[35]	Chan JCY，Taranto GD，Elia R，et al. Postoperative care after lymphaticovenous anastomosis［J］. Arch Plast Surg，2021，48（3）：333-335.
[36]	Becker C，Assouad J，Riquet M，et al. Postmastectomy lymphedema：long-term results following microsurgical lymph node transplantation［J］. Ann Surg，2006，243（3）：313-315.
[37]	Moon KC，Kim HK，Lee TY，et al. Vascularized lymph node transfer for surgical treatments of upper versus lower extremity lymphedema［J］. J Vasc Surg Venous Lymphat Disord，2022，10（1）：170-178.
[38]	Buettner M，Bode U. Lymph Node Transplantation and Its Immunological Significance in Animal Models［J］. Clin Dev Immnol，2011，2011：353510.
[39]	Basta MN，Gao LL，Wu LC. Operative treatment of peripheral lymphedema：a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation［J］. Plast Reconstr Surg，2014，133（4）：905-913.
[40]	向泓雨，刘荫华. 制定高质量临床实践指南推动中国乳腺外科诊治规范化进程［J］，中华普外科手术学杂志（电子版），2022，16（2）：119-123.
[41]	张毅，万安第. 开展中国乳腺外科腔镜手术多中心研究的思考［J］，中华普外科手术学杂志（电子版），2022，16（2）：127-132.

Please choose a citation manager

Content to export